Akebia Therapeutics Inc (AKBA)
1.845
+0.16
(+9.17%)
USD |
NASDAQ |
Nov 04, 16:00
1.85
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics 1 Year Total Returns (Daily): 95.26% for Nov. 4, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 04, 2024 | 95.26% |
November 01, 2024 | 91.61% |
October 31, 2024 | 88.64% |
October 30, 2024 | 101.0% |
October 29, 2024 | 103.5% |
October 28, 2024 | 94.02% |
October 25, 2024 | 98.75% |
October 24, 2024 | 84.36% |
October 23, 2024 | 89.35% |
October 22, 2024 | 97.61% |
October 21, 2024 | 65.08% |
October 18, 2024 | 54.59% |
October 17, 2024 | 46.59% |
October 16, 2024 | 51.12% |
October 15, 2024 | 44.38% |
October 14, 2024 | 45.49% |
October 11, 2024 | 29.41% |
October 10, 2024 | 19.63% |
October 09, 2024 | 26.73% |
October 08, 2024 | 24.53% |
October 07, 2024 | 24.53% |
October 04, 2024 | 19.82% |
October 03, 2024 | 25.71% |
October 02, 2024 | 16.52% |
October 01, 2024 | 12.28% |
Date | Value |
---|---|
September 30, 2024 | 15.79% |
September 27, 2024 | 15.65% |
September 26, 2024 | 13.68% |
September 25, 2024 | 16.81% |
September 24, 2024 | 14.41% |
September 23, 2024 | 11.02% |
September 20, 2024 | 14.17% |
September 19, 2024 | 12.30% |
September 18, 2024 | 8.87% |
September 17, 2024 | 8.73% |
September 16, 2024 | 11.11% |
September 13, 2024 | 19.67% |
September 12, 2024 | 14.29% |
September 11, 2024 | 10.77% |
September 10, 2024 | 15.62% |
September 09, 2024 | 10.94% |
September 06, 2024 | 8.00% |
September 05, 2024 | 13.11% |
September 04, 2024 | 4.89% |
September 03, 2024 | 6.02% |
August 30, 2024 | 10.71% |
August 29, 2024 | -1.30% |
August 28, 2024 | 10.87% |
August 27, 2024 | 32.17% |
August 26, 2024 | 34.78% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.80%
Minimum
Nov 02 2022
379.8%
Maximum
Aug 01 2023
21.64%
Average
-17.10%
Median
1 Year Total Returns (Daily) Benchmarks
Corcept Therapeutics Inc | 95.43% |
Bioventus Inc | 257.0% |
Eli Lilly and Co | 42.91% |
NovaBay Pharmaceuticals Inc | -93.97% |
Palatin Technologies Inc | -43.87% |